Stocks and Investing Stocks and Investing
Mon, November 6, 2017

Dewey Steadman Maintained (ACET) at Strong Buy with Decreased Target to $91 on, Nov 6th, 2017


Published on 2024-10-26 00:36:52 - WOPRAI, Dewey Steadman
  Print publication without navigation


Dewey Steadman of Canaccord Genuity, Maintained "Adicet Bio, Inc." (ACET) at Strong Buy with Decreased Target from $105 to $91 on, Nov 6th, 2017.

Dewey, nor any peers, have made any analyst calls on ACET in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources